3.0(top 20%)
impact factor
561(top 50%)
papers
5.8K(top 20%)
citations
36(top 20%)
h-index
3.1(top 20%)
impact factor
572
all documents
6.6K
doc citations
51(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Intestinal microbiota is altered in patients with colon cancer and modified by probiotic interventionBMJ Open Gastroenterology2017266
2Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsiaBMJ Open Gastroenterology201798
3Cachexia in cancer: what is in the definition?BMJ Open Gastroenterology201697
4Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic reviewBMJ Open Gastroenterology201795
5Mechanisms of liver disease in patients infected with HIVBMJ Open Gastroenterology201791
6Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver diseaseBMJ Open Gastroenterology201690
7High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept studyBMJ Open Gastroenterology201982
8Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohortsBMJ Open Gastroenterology201777
9Novelty in the gut: a systematic review and meta-analysis of the gastrointestinal manifestations of COVID-19BMJ Open Gastroenterology202072
10Impact of introducing a faecal immunochemical test (FIT) for haemoglobin into primary care on the outcome of patients with new bowel symptoms: a prospective cohort studyBMJ Open Gastroenterology201968
11Gut microbiota associated with HIV infection is significantly enriched in bacteria tolerant to oxygenBMJ Open Gastroenterology201666
12Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelinesBMJ Open Gastroenterology202162
13Iron deficiency anaemia: pathophysiology, assessment, practical managementBMJ Open Gastroenterology202259
14Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver diseaseBMJ Open Gastroenterology201658
15Gastric microbiota in the functional dyspepsia patients treated with probiotic yogurtBMJ Open Gastroenterology201657
16Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targetsBMJ Open Gastroenterology201653
17Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disordersBMJ Open Gastroenterology201653
18Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysisBMJ Open Gastroenterology202153
19How bad is bile acid diarrhoea: an online survey of patient-reported symptoms and outcomesBMJ Open Gastroenterology201752
20Growth patterns of colorectal cancer liver metastases and their impact on prognosis: a systematic reviewBMJ Open Gastroenterology201852
21Changes in the gut microbiota composition and the plasma ghrelin level in patients withHelicobacter pylori-infected patients with eradication therapyBMJ Open Gastroenterology201749
22Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre studyBMJ Open Gastroenterology202149
23Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in FinlandBMJ Open Gastroenterology201548
24Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)BMJ Open Gastroenterology201647
25Weight regain after Roux-en-Y gastric bypass has a large negative impact on the Bariatric Quality of Life IndexBMJ Open Gastroenterology201747
26Combination therapy with vedolizumab and etanercept in a patient with pouchitis and spondylarthritisBMJ Open Gastroenterology201747
27Alcohol and hepatocellular carcinomaBMJ Open Gastroenterology201946
28Pitfalls in diagnosis and treatment of alveolar echinococcosis: a sentinel case seriesBMJ Open Gastroenterology201544
29Risk factors for colorectal cancer significantly vary by anatomic siteBMJ Open Gastroenterology201944
30Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery diseaseBMJ Open Gastroenterology201643
31Gallstone ileus: a reviewBMJ Open Gastroenterology201942
32Panenteric capsule endoscopy versus ileocolonoscopy plus magnetic resonance enterography in Crohn’s disease: a multicentre, prospective studyBMJ Open Gastroenterology202042
33Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort studyBMJ Open Gastroenterology202142
34Cost-effectiveness of adalimumab, infliximab or vedolizumab as first-line biological therapy in moderate-to-severe ulcerative colitisBMJ Open Gastroenterology201641
35Duodenal biopsies for the diagnosis of coeliac disease: are we adhering to current guidance?BMJ Open Gastroenterology201739
36Gastrointestinal lymphoma: the new mimicBMJ Open Gastroenterology201939
37Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severityBMJ Open Gastroenterology202239
38The societal burden of chronic liver diseases: results from the COME studyBMJ Open Gastroenterology201538
39Case report and literature review of auto-brewery syndrome: probably an underdiagnosed medical conditionBMJ Open Gastroenterology201938
40Traditional serrated adenoma: an overview of pathology and emphasis on molecular pathogenesisBMJ Open Gastroenterology201938
41A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitisBMJ Open Gastroenterology202137
42Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort studyBMJ Open Gastroenterology201635
43Endoscopic ultrasound (EUS) and the management of pancreatic cancerBMJ Open Gastroenterology202035
44Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational studyBMJ Open Gastroenterology201534
45Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trialBMJ Open Gastroenterology201534
46Safety of dual biological therapy in Crohn’s disease: a case series of vedolizumab in combination with other biologicsBMJ Open Gastroenterology201834
47Pneumatosis intestinalis in COVID-19BMJ Open Gastroenterology202034
48Gut microbiome identifies risk for colorectal polypsBMJ Open Gastroenterology201933
49Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national surveyBMJ Open Gastroenterology202133
50Life in lockdown: experiences of patients with IBD during COVID-19BMJ Open Gastroenterology202032